Literature DB >> 4011060

Oral contraceptives and nonfatal vascular disease.

J B Porter, J R Hunter, H Jick, A Stergachis.   

Abstract

A follow-up study of more than 65,000 healthy women aged 15 to 44 was conducted to assess the association between oral contraceptive use and thromboembolism, stroke, or nonfatal myocardial infarction from 1980 through 1982 at Group Health Cooperative of Puget Sound. A positive association existed between current oral contraceptive use and venous thromboembolism (rate ratio equals 2.8), but there was no positive association between current oral contraceptive use and stroke or myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4011060

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  DoH seems to have underestimated incidence of venous thromboembolism in users of combined oral contraceptives.

Authors:  R A Lawrenson; A Whalley; E Simpson; R D Farmer
Journal:  BMJ       Date:  1999-08-07

Review 2.  Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.

Authors:  Lamberto Manzoli; Corrado De Vito; Carolina Marzuillo; Antonio Boccia; Paolo Villari
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

3.  Assisted reproduction in a patient with Klippel-Trenaunay syndrome: management of thrombophilia and consumptive coagulopathy.

Authors:  J Ryan Martin; Salley G Pels; Michael Paidas; Emre Seli
Journal:  J Assist Reprod Genet       Date:  2010-12-29       Impact factor: 3.412

4.  [Pulmonary embolism with paradoxical coronary and peripheral arterial embolization. Increased risk of thrombosis caused by contraception with desogestrel and ethinylestradiol?].

Authors:  J Brockmeier; J Carlsson; S Miketic; R Meierhenrich; E Sorges; L Obergassel; U Tebbe
Journal:  Med Klin (Munich)       Date:  1997-01-15

5.  A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.

Authors:  R D Farmer; R A Lawrenson; J C Todd; T J Williams; K D MacRae; F Tyrer; G M Leydon
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

Review 6.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 7.  Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.

Authors:  Rachel E J Roach; Frans M Helmerhorst; Willem M Lijfering; Theo Stijnen; Ale Algra; Olaf M Dekkers
Journal:  Cochrane Database Syst Rev       Date:  2015-08-27

8.  Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.

Authors:  Susan S Jick; Rohini K Hernandez
Journal:  BMJ       Date:  2011-04-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.